InsiderClue
Stocks · Health care · Pharmaceutical Preparations

Johnson & Johnson

JNJ Clue Score64
United States Fiscal year ends January CIK 0000200406 Results filed 13 Oct 2026
Add to watchlist

What the insiders did Net selling

Individual transactions

33
Insider
Date
Role
Action
Shares
Price
Amount
Timothy Schmid
2 Sep 2026
EVP, WW Chair, MedTech
Sold after exercise
22,527
$274.74
$6.19M
Timothy Schmid
2 Sep 2026
EVP, WW Chair, MedTech
Sold after exercise
11,070
$274.74
$3.04M
Jennifer L Taubert
17 Aug 2026
EVP, WWC. Innovative Medicine
Sold after exercise
15,000
$263.36
$3.95M
Joaquin Duato
13 Aug 2026
CEO and Chairman of the Board
Sold after exercise
102,315
$261.00
$26.70M
Joaquin Duato
13 Aug 2026
CEO and Chairman of the Board
Sold after exercise
20,976
$262.00
$5.50M
Elizabeth Forminard
6 Aug 2026
EVP, Chief Legal Officer
Sold after exercise
6,574
$255.93
$1.68M
Elizabeth Forminard
6 Aug 2026
EVP, Chief Legal Officer
Sold after exercise
9,344
$257.76
$2.41M
Joaquin Duato
5 Aug 2026
CEO and Chairman of the Board
Sell
6,523
$258.74
$1.69M
Joaquin Duato
5 Aug 2026
CEO and Chairman of the Board
Sell
41,957
$258.06
$10.83M
Vanessa Broadhurst
20 Jul 2026
EVP, Global Corp Affairs
Sold after exercise
23,054
$251.27
$5.79M
Kathryn E Wengel
11 Jun 2026
EVP, Chief TO and Risk Officer
Sold after exercise
10,000
$241.15
$2.41M
Robert J Decker
27 Feb 2026
VP Corporate Controller
Sold after exercise
4,075
$247.87
$1.01M
Timothy Schmid
20 Feb 2026
EVP, WW Chair, MedTech
Sell
1,322
$245.66
$324.76K
Timothy Schmid
18 Feb 2026
EVP, WW Chair, MedTech
Sold after exercise
8,998
$244.53
$2.20M
Timothy Schmid
18 Feb 2026
EVP, WW Chair, MedTech
Sold after exercise
13,625
$244.20
$3.33M
Vanessa Broadhurst
17 Feb 2026
EVP, Global Corp Affairs
Sell
6,197
$243.39
$1.51M
John C Reed
17 Feb 2026
EVP, Innovative Medicine, R&D
Sold after exercise
2,283
$243.00
$554.77K
John C Reed
17 Feb 2026
EVP, Innovative Medicine, R&D
Sold after exercise
29,927
$243.00
$7.27M
John C Reed
17 Feb 2026
EVP, Innovative Medicine, R&D
Sold after exercise
21,721
$243.00
$5.28M
Joseph J Wolk
17 Feb 2026
Exec VP, CFO
Sold after exercise
24,961
$242.68
$6.06M
Joseph J Wolk
17 Feb 2026
Exec VP, CFO
Sold after exercise
33,386
$242.75
$8.10M
Joseph J Wolk
17 Feb 2026
Exec VP, CFO
Sold after exercise
12,066
$242.87
$2.93M
Joseph J Wolk
17 Feb 2026
Exec VP, CFO
Sold after exercise
19,241
$242.99
$4.68M
James D. Swanson
17 Feb 2026
EVP, CIO
Sold after exercise
20,521
$242.70
$4.98M
James D. Swanson
13 Feb 2026
EVP, CIO
Sold after exercise
22,191
$243.71
$5.41M
James D. Swanson
13 Feb 2026
EVP, CIO
Sold after exercise
19,368
$243.76
$4.72M
Kathryn E Wengel
6 Feb 2026
EVP, Chief TO and Risk Officer
Exercised, kept
38,945
$101.87
$3.97M
Kristen Mulholland
6 Feb 2026
EVP, Chief HR Officer
Exercised, kept
5,625
$101.87
$573.02K
Timothy Schmid
6 Feb 2026
EVP, WW Chair, MedTech
Exercised, kept
15,571
$101.87
$1.59M
Elizabeth Forminard
5 Feb 2026
EVP, Chief Legal Officer
Exercised, kept
8,921
$129.51
$1.16M
Joaquin Duato
26 Jan 2026
CEO and Chairman of the Board
Sell indirect
48,782
$221.48
$10.80M
Joaquin Duato
26 Jan 2026
CEO and Chairman of the Board
Sell indirect
51,218
$220.99
$11.32M
John G Morikis
26 Nov 2025
Director
Buy
1,250
$206.15
$257.69K

What was left out

Form 4 filings counted 60
Amendments (4/A) skipped 1
Filings about a different issuer 4
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 22
Sales at will 6
Transactions with no price 0
Shares from compensation/vesting 903,945
History held since 3 Oct 2006